Similarly, Maxwell et al. showed that in a multidrug resistance mouse model of colitis, exacerbation was associated with IL-17A or IL-17RA inhibition, accompanied with a severe weakening of the intestinal epithelial barrier and augmented colonic inflammation [104]. This evidence concerns the gene IL17A and colitis.